Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Frontiers in Bioengineering and Biotechnology|March 12, 2020
Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic RetinopathyRosario Amato, Martina Giannaccini, Massimo Dal Monte, et al.
Molecular Pharmacology|June 16, 2005
Increased Bcl2 expression by antisense oligoribonucleotides targeting the adenine-uridine-rich element motifLaura Ghisolfi, Laura Papucci, Annamaria Bevilacqua, et al.
Cancer Gene Therapy|March 15, 2003
Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozymeEttore Luzi, Laura Papucci, Nicola Schiavone, et al.
Oncogene|June 23, 2004
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by AktLaura Asnaghi, Angela Calastretti, Annamaria Bevilacqua, et al.
Stem Cells International|November 10, 2017
The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene AddictionGiulia Cheloni, Martina Poteti, Silvia Bono, et al.
Biomedicines|August 26, 2022
Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann-Pick Type CClaudia Capitini, Federica Feo, Anna Caciotti, et al.
International Journal of Molecular Sciences|December 11, 2022
Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma CellsSilvia Peppicelli, Jessica Ruzzolini, Matteo Lulli, et al.
The Journal of Biological Chemistry|February 11, 2004
Identification of TINO: a new evolutionarily conserved BCL-2 AU-rich element RNA-binding proteinMartino Donnini, Andrea Lapucci, Laura Papucci, et al.
Oncogene|March 17, 2004
LMW-PTP is a positive regulator of tumor onset and growthPaola Chiarugi, Maria Letizia Taddei, Nicola Schiavone, et al.
Blood Advances|April 23, 2021
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNsManjola Balliu, Laura Calabresi, Niccolò Bartalucci, et al.
Pageof 11